Moolec Science (MLECW) Net Income - Minority (2022 - 2025)
Moolec Science (MLECW) posted Net Income - Minority of $153317.0 for Q4 2025, down 96.09% sequentially from $3.9 million in Q4 2024, and down 96.09% YoY from $3.9 million in Q4 2024.
Moolec Science (MLECW) Net Income - Minority (2022 - 2025) Analysis & Trends
Moolec Science has reported Net Income - Minority for 4 years, with the latest figure at $153317.0 in Q4 2025.
- Quarterly Net Income - Minority fell 96.09% year-over-year to $153317.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $153317.0 (down 96.09% YoY) and the FY2024 annual result came in at -$3.6 million, up 71.43% from the prior year.
- Net Income - Minority eased to $153317.0 in Q4 2025 per MLECW's latest filing, from $3.9 million in the prior quarter.
- Over five years, Net Income - Minority peaked at $13.4 million in Q2 2022 and troughed at -$12.7 million in Q2 2023.
- A 4-year average of $558306.7 and a median of $1.2 million in 2023 frame the typical range for Net Income - Minority.
- The sharpest annual moves came in 2023 and 2024: Net Income - Minority tumbled 194.81% in 2023, then soared 77.89% in 2024.
- Over 4 years, Net Income - Minority stood at $13.4 million in 2022, then slumped by 83.52% to $2.2 million in 2023, then surged by 77.89% to $3.9 million in 2024, then slumped by 96.09% to $153317.0 in 2025.
- According to Business Quant data, Net Income - Minority over the past three periods registered $153317.0, $3.9 million, and -$3.6 million for Q4 2025, Q4 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income - Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 153,317.00 |
| Dec 31, 2024 | 3.92 Mn |
| Jun 30, 2024 | -3.62 Mn |
| Dec 31, 2023 | 2.20 Mn |
| Jun 30, 2023 | -12.69 Mn |
| Jun 30, 2022 | 13.38 Mn |